2021北美放射学会年会:分子核医学  

2021 Radiological Society of North America annual meeting:molecular nuclear medicine

作　　者：孙伟晟 徐淑敏 裴妮慧 王培军[3] 曾洪武[2] Sun Weisheng;Xu Shumin;Pei Nihui;Wang Peijun;Zeng Hongwu(Shantou University Medical College,Shantou 515041,China;Department of Radiology,Shenzhen Children′s Hospital,Shenzhen 518038,China;Department of Radiology,Tongji Hospital of Tongji University,Shanghai 200065,China)

机构地区：[1]汕头大学医学院,汕头515041 [2]深圳市儿童医院放射科,深圳518038 [3]同济大学附属同济医院放射科,上海200065

出　　处：《中华核医学与分子影像杂志》2022年第3期177-180,共4页Chinese Journal of Nuclear Medicine and Molecular Imaging

基　　金：国家自然科学基金(81771889);深圳市科技计划项目(201884480);深圳市医疗卫生三名工程项目(SZSM202011005)。

摘　　要：分子核医学是利用核医学技术研究生物体中分子水平的变化,从而了解其功能变化的新型学科。2021北美放射学会年会有40余篇以分子核医学为主题的学术报告,主要内容有新型显像剂和新影像学显像方法在肿瘤(前列腺癌、乳腺癌、直肠癌等)以及其他疾病[新型冠状病毒肺炎(COVID-19)、阿尔茨海默病、帕金森病等]中的应用。该文将对相关研究进展进行综述。Molecular nuclear medicine is a new subject that uses nuclear medicine technology to study the changes of molecular level in organisms in order to understand their functional changes.2021 Radiological Society of North America annual meeting has more than 40 academic reports on molecular nuclear medicine.The main content includes new tracers and new imaging methods in tumors(prostate cancer,breast cancer,rectal cancer,etc.)and other diseases(Coronavirus Disease 2019(COVID-19),Alzheimer′s disease,Parkinson′s disease,etc.).This article reviews the relevant research progress.

关 键 词：核医学 分子显像 发展趋势 

分 类 号：R817[医药卫生—影像医学与核医学]